Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.13), $0.20 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $183.6 million versus the consensus estimate of $172.72 million.

GUIDANCE:

Novocure sees FY2026 revenue of $710-725 million, versus the consensus of $708.7 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.